Skip to content

Failed Induction of Labor Is Infrequent According to Contemporary Standardized Definition

Key findings

  • Between July 1, 2016, and June 30, 2019, 4,123 nulliparous women had labor induced and delivered a liveborn singleton at 39 to 41-6/7 weeks of gestation at Massachusetts General Hospital and its partner hospitals
  • 82 women (2%) experienced failure of induction according to the Obstetric Care Consensus criteria of the American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine
  • In a comparison of those 82 women and 328 controls, risk factors associated with failed induction of labor were obesity, shorter stature and cervical dilatation <2 cm at admission
  • The rate of failed induction of labor was low even among women who had labor induced for maternal or fetal indications

In 2014, the American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine published a joint Obstetric Care Consensus on diagnosing failed induction of labor. However, there is still little information about the incidence of failed induction using this standardized definition.

In a case–control study, Mark A. Clapp, MD, MPH, a specialist in the Maternal-Fetal Medicine Program, and colleagues in the Department of Obstetrics and Gynecology at Massachusetts General Hospital found that failed induction of labor according to the standardized definition occurs infrequently, even among women who have certain risk factors they identified. Their report appears in Obstetrics & Gynecology.

Study Methods

Between July 1, 2016, and June 30, 2019, at Mass General and its partner hospitals, 4,123 nulliparous women had labor induced and delivered a liveborn singleton at 39 to 41-6/7 weeks of gestation. Failed induction was defined according to Obstetric Care Consensus criteria:

  • Cesarean delivery was required for "failure to progress" or "failed induction" in the first stage of labor
  • The last documented cervical dilatation was <6 cm
  • Oxytocin was administered for ≥12 hours after rupture of membranes

82 women (2%) experienced a failed induction. Each was matched by hospital site and date of admission with four nulliparous control subjects, induced during the same time period, who did not meet the criteria for failed induction.

Risk Factors and Protective Factors

  • Factors positively associated with failed induction were body mass index (BMI) at delivery of 30.0–39.9 kg/m2 (adjusted OR, 2.42) and BMI ≥40 kg/m2 (aOR, 7.93) compared with BMI <30 kg/m2
  • Factors negatively associated with failed induction were height (aOR, 0.89 per additional inch) and cervical dilatation at the admission of ≥2 cm (aOR, 0.30)
  • Indications for induction—fetal concern, late-term or maternal comorbidities (e.g., advanced maternal age, chronic hypertension, hypertensive disorders of pregnancy, pregestational or gestational diabetes)—did not influence the odds of failed induction

Counseling Patients

The information from this study can be used to reassure women that the overwhelming majority of women who are induced achieve active labor, even those induced for maternal medical or fetal indications.

One question is whether the definition of failure of induction is appropriate for women with obesity. 12 hours of oxytocin administration may be too conservative a criterion—some women with high BMI might go on to deliver vaginally if given more time in the latent phase.

2%
rate of failed induction among nulliparous women with singleton gestations

2x
greater risk of failed induction among nulliparous women with singleton gestations whose BMI was 30.0–39.9 kg/m2 at delivery

Learn more about the Maternal-Fetal Medicine Program

Refer a patient to the Obstetrics Program at Mass General

Related topics

Related

In this video, Allison S. Bryant, MD, MPH, vice chair of quality, equity and safety in the Department of Obstetrics and Gynecology at Massachusetts General Hospital, discusses how the department is integrating practices and training to increase equity in patient care—locally and on a regional and national level.

Related

Anjali J. Kaimal, MD, MAS, director of the Deborah Kelly Center for Clinical Research in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital, discusses how the center facilitates and supports obstetrics and gynecologic research.